×
Elekta AB EBIT 2013-2025 | EKTAY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Elekta AB ebit from 2013 to 2025. Ebit can be defined as earnings before interest and taxes.
View More
Elekta AB EBIT 2013-2025 | EKTAY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Elekta AB ebit from 2013 to 2025. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
Intuitive Surgical (ISRG)
$171.9B
Thermo Fisher Scientific (TMO)
$161.4B
Alcon (ALC)
$45.6B
Edwards Lifesciences (EW)
$42B
IDEXX Laboratories (IDXX)
$33.3B
DexCom (DXCM)
$26.9B
IQVIA Holdings (IQV)
$25.4B
STERIS (STE)
$21.8B
Mettler-Toledo (MTD)
$20.9B
Waters (WAT)
$19.1B
SONOVA HOLDING (SONVY)
$17.3B
Fresenius Medical Care AG KGaA (FMS)
$13.9B
Hologic (HOLX)
$12.9B
Sysmex ADR (SSMXY)
$11.8B
Penumbra (PEN)
$10.7B
Globus Medical (GMED)
$9.8B
Masimo (MASI)
$8.2B
Teleflex (TFX)
$6B
Glaukos (GKOS)
$5.2B
Integer Holdings (ITGR)
$4.1B
TransMedics (TMDX)
$3B
PROCEPT BioRobotics (PRCT)
$2.9B
Veracyte (VCYT)
$2.4B
Nihon Kohden (NHNKY)
$2.1B
LivaNova (LIVN)
$1.9B
Alphatec Holdings (ATEC)
$1.5B
Integra LifeSciences Holdings (IART)
$1.2B
Pulse Biosciences (PLSE)
$1.2B
Tandem Diabetes Care (TNDM)
$1.1B
Paragon 28 (FNA)
$1.1B